News
05 Nov University of Kentucky Research Foundation and ValidCare Partner to Research Hemp
Lexington, KY and Centennial, CO., November 5, 2019 – ValidCare, the hemp industry’s leading market intelligence and consumer research platform, and the University of Kentucky Research Foundation (UKRF) today announced they have entered into a services agreement to advance the research of hemp-derived products. The...
24 Sep ValidCare Launches National Program to Share CBD Real World Evidence with FDA
Leading CBD product companies deploy the CBD+me™ platform to collect consumer data to address the FDA’s questions on the safety and efficacy of cannabis-derived products Centennial, Colo. – September 24, 2019 – ValidCare, the market intelligence platform for the canna-based product industry, announced a first-of-its-kind National Consumer...
04 Sep Hemp Industries Association and ValidCare Strategic Alliance Will Provide CBD Market Intelligence Solution for Members
HIA members offering hemp-derived CBD products can power their business strategies with consumer-driven market intelligence Phoenix, Ariz. and Centennial, Colo. – September 04, 2019 – The Hemp Industries Association® (HIA®), a non-profit trade association consisting of more than 1,600 members, and ValidCare, the market intelligence leader for the...
22 Aug ValidCare Launches National Consumer Experience Program to Gather CBD Real World Evidence for FDA
New program and consumer application bring an industry-level approach to consumer data to address the FDA’s questions on the safety and efficacy of cannabis-derived products Centennial, Colo. – August 22, 2019 – ValidCare, the market intelligence leader for the canna-based product industry, announced a first of...
13 Aug ValidCare to Present at CBOutlook on Critical Need for Real World Evidence on CBD
CEO McCarthy will discuss the need for an industry-level approach to consumer data to address the FDA’s pressing questions on the safety and efficacy of cannabis-derived products Centennial, Colo. – August 13, 2019 – ValidCare, the market intelligence leader for the CBD market, announced that CEO...
12 Aug Join us now for the CBD Consumer Experience Program
FDA has pressing questions about safety and efficacy of CBD when used by specific populations and for specific purposes. In a recent post from the FDA, Amy Abernethy, M.D., Ph.D., Principal Deputy Commissioner, stated “Science forms the basis for decisions at the U.S. Food and Drug...
06 Aug How Will FDA Treat CBD from Hemp – Is it a Food or a Drug?
In a recent discussion of industry thought leaders, our round table participants considered what FDA may do as they consider how to regulate hemp, especially as more and more consumers find value in hemp-derived CBD use. The question at hand: will FDA determine that CBD...
31 Jul Will Standards Help Protect Hemp Workers?
In a recent discussion of industry thought leaders, our round table discussion turned toward safety of workers in the hemp industry. This discussion was led by Dr. Philip Kaufmann, who is a practicing MD and certified allergist immunologist. Patrick McCarthy, ValidCare: Dr. Kaufmann, you made an...
30 Jul ValidCare Launches First Adverse Event and Safety Reporting Application for CBD Products
CBD market is expected to grow to $22 billion by 20221 with products claiming to address a wide range of serious health concerns and no ability to track adverse events in a “let the buyer beware” environment. Centennial, Colo. – July 30, 2019 – The CBD...